ArticleJACC. Case reports2025
Long-Term Sequential Percutaneous Treatment in Takayasu's Arteritis With Pulmonary Artery Involvement as the Initial Presentation.
Article in JACC. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTakayasu's arteritis (TA) is a rare inflammatory disease affecting large vessels, with pulmonary artery involvement being uncommon and challenging to manage. CASE SUMMARY: A 46-year-old woman with severe pulmonary hypertension, initially diagnosed with TA, presented with left pulmonary artery stenosis and right pulmonary artery total occlusion. After a series of percutaneous interventions over 20 years, the patient avoided lung transplantation and achieved stable long-term outcomes. DISCUSSION: This case is of particular interest due to the rare pulmonary involvement in TA and the successful management of chronic total pulmonary artery occlusion through sequential percutaneous interventions. The extended 20-year follow-up is exceptional, as long-term outcomes in similar cases are rarely documented. TAKE-HOME MESSAGE: Percutaneous treatments can provide significant long-term benefits in managing pulmonary artery involvement in TA, even in complex cases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.